Overview

Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss.
Phase:
Phase 2
Details
Lead Sponsor:
Autifony Therapeutics Limited